Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,151 | 16,723 | 9,361 | 13,391 | 3,792 |
| Other current assets | 3,201 | 2,711 | 2,264 | 1,304 | 1,012 |
| TOTAL | $11,352 | $19,433 | $11,625 | $14,695 | $4,804 |
| Non-Current Assets | |||||
| Intangibles | 0 | 21 | 23 | 0 | 26 |
| Other Non-Current Assets | 19 | 0 | 0 | 24 | 0 |
| TOTAL | $19 | $21 | $23 | $24 | $26 |
| Total Assets | $11,371 | $19,455 | $11,648 | $14,719 | $4,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,635 | 3,076 | 1,789 | 1,923 | 1,685 |
| Accrued Expenses | 1,411 | 2,448 | 3,185 | 1,433 | 1,557 |
| Other current liabilities | N/A | N/A | 1,120 | N/A | N/A |
| TOTAL | $3,045 | $5,524 | $6,093 | $3,356 | $3,242 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,045 | $5,524 | $6,093 | $3,356 | $3,242 |
| Shareholders' Equity | |||||
| Common Shares | 594 | 594 | 476 | 476 | 397 |
| Retained earnings | -210,561 | -204,881 | -199,705 | -193,917 | -192,466 |
| Other shareholders' equity | 51,572 | 51,620 | 51,653 | 51,746 | 51,774 |
| TOTAL | $8,326 | $13,931 | $5,555 | $11,363 | $1,588 |
| Total Liabilities And Equity | $11,371 | $19,455 | $11,648 | $14,719 | $4,830 |